L26/P-866 Ovarian Response Prediction Index (ORPI) as a practical quality and safety tool in routine ART stimulation: a real-world study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von B.C. Matuella und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Study question In routine ART practice, can the Ovarian Response Prediction Index(ORPI) identify patients at risk of poor or excessive ovarian response and support safer ovarian stimulation? Summary answer ORPI reliably identified patients with poor and excessive ovarian response and supported safer, more individualised FSH dosing. However, its ability to predict pregnancy was limited. What is known already Accurate prediction of ovarian response enables clinicians in assisted reproduction to individualise gonadotrophin dosing and minimise adverse effects. Both poor and excessive ovarian responses reduce the efficiency and safety of ART, increasing cycle cancellation rates and the risk of ovarian hyperstimulation syndrome(OHSS). Anti-Müllerian hormone (AMH), antral follicle count(AFC) and patient age are established predictors, but each has limitations and offers incomplete risk stratification when used alone. The ORPI integrates these parameters into a single index to support more standardised and individualised stimulation strategies. However, real-world data on ORPI performance remain scarce. Study design, size, duration This cohort study included 1,876 patients undergoing ART over the past four years, with no eligibility restrictions. ORPI was calculated as described in studies published since 2012 (ORPI=AMH[ng/mL] × AFC[2–9 mm] / age [years]). AMH and AFC were assessed in a prior cycle. The ovarian stimulation protocol was selected at the treating clinician’s discretion, and the starting dose of follicle-stimulating hormone (FSH) was determined according to ORPI to support individualised dosing in routine clinical practice. Participants/materials, setting, methods Endpoints included total FSH dose, follicle count, number of oocytes retrieved (total and mature [MII]), number of embryos and clinical pregnancy. Associations between ORPI and outcomes were evaluated using Spearman’s rank correlation and logistic regression, as appropriate. Discriminative performance was assessed using receiver operating characteristic (ROC) curve analysis for clinically relevant thresholds: ≤3 oocytes (poor response), ≥15 oocytes (excessive response), ≥4 MII oocytes and clinical pregnancy. Main results and the role of chance The mean(±SD) ORPI was 1.11±2.48, with a mean age of 36.7±4.4years, mean AMH concentration of 2.12±3.23ng/mL, and mean AFC of 12.32±7.1. ORPI values were associated with total FSH dose and follicle numbers, oocyte yield, MII oocytes and embryo number (all P<0.001). Spearman analyses showed a significant negative association between ORPI and total FSH dose (r = −0.50; 95%CI:−0.53/−0.47;P<0.001). ORPI was positively associated with follicle counts ≥10 mm(r = 0.74;95%CI:0.71/0.76;P<0.001) and ≥18mm(r = 0.57;95%CI:0.53/0.60;P<0.001), as well as total oocytes (r = 0.66; 95%CI:0.64/0.69; P<0.001), MII oocytes(r = 0.62; 95%CI:0.58/0.65; P<0.001), and total embryos (r = 0.54;95%CI 0.51/0.57;P<0.001). ORPI was significantly associated with both poor response(≤3oocytes) and excessive response(≥15oocytes), showing good discrimination for these outcomes (area under the curve AUC>0.80). Prediction of clinical pregnancy was statistically significant but modest. In logistic regression, ORPI values were significantly associated with the likelihood of retrieving ≤3oocytes(OR:0.45;95%CI:0.38/0.54;P<0.001), ≥15oocytes (OR:1.25; 95%CI:1.18/1.34;P<0.001) and ≥4MIIoocytes (OR:1.72; 95%CI:1.50/1.96; P<0.001). ORPI was also significantly associated with clinical pregnancy (OR:1.09;95%CI:1.04/1.14;P<0.001). For predicting retrieval of ≤ 3oocytes, the AUC was 0.85, with 76% sensitivity and 81% specificity. For ≥15oocytes, the AUC was 0.83, with 70% sensitivity and 80% specificity. For ≥4 MII oocytes, the AUC was 0.81, with 78% sensitivity and 73% specificity. For clinical pregnancy, the AUC was 0.65, with 53% sensitivity and 70% specificity. Limitations, reasons for caution As ORPI was used to guide the starting FSH dose, incorporation bias cannot be excluded. Variability in AMH assays, AFC methodology, ovarian-response definitions, and stimulation protocols may act as confounders. Pregnancy prediction was limited and influenced by factors beyond ovarian response. Wider implications of the findings In real-world ART practice, ORPI is a simple tool that improves the safety and consistency of ovarian stimulation.Importantly, ORPI could be a fundamental component of zero-tolerance programmes for ovarian hyperstimulation syndrome, supporting early risk identification and the prevention of extreme responses.Although ORPI improves quality/safety, pregnancy prediction needs additional clinical-embryological factors. Trial registration number No
Zitieren
APA
Matuella, B., Petersen, C., Vagnini, L., Masaro, F., Petersen, B., Nicoletti, A., Ricci, J., Santo, E. E., Zamara, C., Pasotti, I., Pouza, R., Meziara, J., Oliveira, J., & Franco, J. (2026). L26/P-866 Ovarian Response Prediction Index (ORPI) as a practical quality and safety tool in routine ART stimulation: a real-world study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1190
Vancouver
Matuella B, Petersen C, Vagnini L, Masaro F, Petersen B, Nicoletti A, et al. L26/P-866 Ovarian Response Prediction Index (ORPI) as a practical quality and safety tool in routine ART stimulation: a real-world study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1190
BibTeX
@article{Matuella2026,
author = {Matuella, B.C. and Petersen, C.G. and Vagnini, L.D. and Masaro, F.C. and Petersen, B. and Nicoletti, A. and Ricci, J. and Santo, E.V. Espirito and Zamara, C. and Pasotti, I.M. and Pouza, R.A. and Meziara, J.B. and Oliveira, J.B.A. and Franco, J.G.},
title = {L26/P-866 Ovarian Response Prediction Index (ORPI) as a practical quality and safety tool in routine ART stimulation: a real-world study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1190}
}
EUVIMED